United States - English - NLM (National Library of Medicine)

strides pharma science limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

dr. reddys laboratories limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast tablets are contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

avpak - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients.

United States - English - NLM (National Library of Medicine)

american health packaging - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast tablets are contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

carilion materials management - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients.

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

avkare - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.